News

The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.

Researchers have identified how immune-based cancer treatment can cause colitis, and have found a new way to deliver immunotherapy without this side effect.

A promising drug target has been identified for a subset of acute myeloid leukemia that responds poorly to conventional treatment.

UC Riverside researchers have found a way to rein MYC, the shapeless protein responsible for making the majority of human cancer cases worse in. Offering hope for a new era of treatments.

A bioengineered "supercharged" immune cell has been designed that is particularly efficient at targeting and destroying cancer cells.

Mutations of the tumor suppressor p53 not only have a growth-promoting effect on the cancer cells themselves, but also influence the cells in the tumor's microenvironment

Penn Medicine researchers developed an artificial intelligence tool to quickly analyze gene activities in medical images and provide single-cell insight into diseases in tissues and tissue microenvironments.

Next-generation sequencing analysis suggests that revising cancer care guidelines could allow 6,000 more cancer patients each year to benefit from immunotherapy.

The research team has successfully developed unprecedented “NK cell-engaging nanodrones” capable of selectively targeting and eliminating cancer cells, offering a potential solution for intractable types of cancers.

Nearly 8 in 10 women develop fibroids, noncancerous tumors that develop in the uterus during child-bearing years. Researchers found different signaling pathways being used by the fibroid cells compared to the uterine cells.